JIR
TDOC icon

James Investment Research’s Teladoc Health TDOC Stock Holding History

James Investment Research’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-553
Closed -$121K – 544
2020
Q3 		$121K Buy
553
+217
+65% +$46K 0.01% 278
2020
Q2 		$64K Sell
336
-124
-27% -$21.7K 0.01% 305
2020
Q1 		$71K Buy
+460
New +$53.5K 0.01% 282
2019
Q4 		– Sell
-1,640
Closed -$111K – 552
2019
Q3 		$111K Buy
1,640
+590
+56% +$38.8K 0.01% 349
2019
Q2 		$70K Hold
1,050
– – 0.01% 475
2019
Q1 		$58K Buy
+1,050
New +$64.1K ﹤0.01% 634

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

James Investment Research's TDOC Position: Q4 2020 in Review

James Investment Research sold out of Teladoc Health (TDOC) in Q4 2020, closing a stake of 553 shares — an estimated $121K sold.

James Investment Research first reported a position in TDOC in Q1 2019 and held it in 6 quarters. The position peaked at $121K in Q3 2020. 901 funds tracked by Wall St. Rank hold TDOC as of Q4 2020.

  • James Investment Research reported no remaining Teladoc Health position as of Q4 2020 after selling out during the quarter.
  • James Investment Research sold 553 Teladoc Health shares in Q4 2020, an estimated $121K.
  • James Investment Research first reported a position in Teladoc Health in Q1 2019 and held it in 6 quarters.
  • James Investment Research's Teladoc Health position peaked at $121K in Q3 2020.
  • 901 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2020.

Based on James Investment Research's 13F filing for Q4 2020, filed 27 Jan 2021.